NCT03861507 Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound
| NCT ID | NCT03861507 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Western University, Canada |
| Condition | Prostate Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2020-03-04 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2020-03-04 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study involves patients who are scheduled for standard care brachytherapy of focal tumours within the prostate, which is normally performed under standard 2-dimensional (2D) ultrasound guidance. The purpose of this study is the acquire power Doppler ultrasound while using a simple oscillator in physical contact with the end of a brachytherapy needle. The vibrations along the needle should be visible in the power Doppler ultrasound, helping to visualize the needle position within the anatomy.
Eligibility Criteria
Inclusion Criteria: * Male, aged 18 years or older * Willing to provide written consent * Pathologically confirmed prostate cancer on previous biopsy * Suitable for and consenting to high-dose-rate brachytherapy for treatment as standard of care. Exclusion Criteria: * • Previous radiotherapy to the prostate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03861507 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03861507 currently recruiting?
Yes, NCT03861507 is actively recruiting participants. Contact the research team at afenster@uwo.ca for enrollment information.
Where is the NCT03861507 trial being conducted?
This trial is being conducted at London, Canada.
Who is sponsoring the NCT03861507 clinical trial?
NCT03861507 is sponsored by Western University, Canada. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.